You are here

  • Home
  • Archive
  • Volume 78, Issue Suppl 2
  • THU0561 CANAKINUMAB FOR THE TREATMENT OF ADULT ONSET STILL‘S DISEASE TO ACHIEVE REDUCTION OF ARTHRITIC MANIFESTATION AT WEEK 12: AN INVESTIGATOR-INITIATED MULTI-CENTRE, PLACEBO-CONTROLLED STUDY (CONSIDER)

Article metrics

Article menu

Download PDFPDF

Poster Presentations
THURSDAY, 13 JUNE 2019
Other orphan diseases
THU0561 CANAKINUMAB FOR THE TREATMENT OF ADULT ONSET STILL‘S DISEASE TO ACHIEVE REDUCTION OF ARTHRITIC MANIFESTATION AT WEEK 12: AN INVESTIGATOR-INITIATED MULTI-CENTRE, PLACEBO-CONTROLLED STUDY (CONSIDER)
Free

 

Online download statistics by month:

Online download statistics by month: June 2019 to March 2024

AbstractFullPdf
Jun 201934029
Jul 201953014
Aug 201943011
Sep 20193004
Oct 201953011
Nov 20196208
Dec 201934010
Jan 20205204
Feb 20203907
Mar 20204509
Apr 20201003
May 20201705
Jun 20202409
Jul 20201302
Aug 20201803
Sep 20203802
Oct 20203204
Nov 20202405
Dec 20201600
Jan 20211503
Feb 2021401
Mar 202124010
Apr 20211402
May 2021703
Jun 2021004
Jul 2021009
Aug 2021001
Sep 2021001
Oct 202115018
Nov 202123015
Dec 2021901
Jan 20221504
Feb 2022601
Mar 2022602
Apr 2022400
May 2022709
Jun 2022603
Jul 20222003
Aug 20223606
Sep 2022608
Oct 2022402
Nov 2022401
Dec 2022902
Jan 20231206
Feb 20231800
Mar 20231300
Apr 2023001
May 2023402
Jun 2023802
Jul 2023406
Aug 2023804
Sep 2023402
Oct 20231703
Nov 20231001
Dec 20232202
Jan 2024801
Feb 2024804
Mar 20244054
Total10110337